Phase 4 Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 60 and 85 years old (inclusive)
- You have been diagnosed with a type of epilepsy called "focal epilepsy" (where seizures start in one part of the brain) for at least 2 years, based on current medical standards
- You have been taking the same epilepsy medication(s) steadily for at least 3 months, and your seizures are reasonably controlled (no more than 4 seizures per month over the past 3 months)
- You have mild memory or thinking difficulties, shown by a specific memory test score (called the MoCA) between 18 and 25 out of 30
- You can understand and speak basic Chinese well enough to take part in thinking and memory tests
- You are willing to take part and have signed a consent form agreeing to join the study
Who may not be able to join:
- You have been diagnosed with any type of dementia, such as Alzheimer's disease or vascular dementia
- You have had a stroke that showed up on a brain scan, or your brain MRI shows serious damage to the white matter (the brain's communication pathways)
- You have another brain or nervous system condition that could affect your memory or thinking, such as a brain injury, brain infection, or fluid build-up in the brain
- You have a serious illness affecting your whole body — such as severe heart, liver, or kidney problems, or a hormonal condition — that could affect your thinking
- You currently have severe depression or another mental health condition that could affect your thinking and memory test results
- You have a history of dependence on alcohol, drugs, or other substances that could affect brain function
- You are allergic to a medication called butylphthalide or any of its ingredients
- You have taken part in another drug clinical trial within the past 30 days
- The trial doctors have decided for any other reason that the trial would not be appropriate for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Huiqin Xu, MD, Department of Neurology, First Affiliated Hospital of Wenzhou Medical University
Phone: +86-13858806368
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Montreal Cognitive Assessment (MoCA) Total Score from Baseline to 48 Weeks
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.